IL-6 is produced by osteoblasts and induces bone resorption

Area of Science:

• Bone Biology and Metabolism
• Cell Signaling
• Immunology

Background:

• Interleukin-6 (IL-6) is a cytokine with known roles in inflammation and immunity.
• Its specific involvement in bone metabolism, particularly osteoblast function and bone resorption, requires further elucidation.

Purpose of the Study:

• To investigate the production of IL-6 by osteoblasts.
• To determine the effect of IL-6 on bone resorption and osteoblast activity.
• To examine the influence of various bone-resorbing agents on IL-6 expression in osteoblasts.

Main Methods:

• Culturing of mouse osteoblastic cell line (MC3T3-E1) and primary osteoblast-like cells.
• Treatment with systemic and local bone-resorbing agents (e.g., IL-1α, TNF-α, LPS, PTH, 1α,25-dihydroxyvitamin D3).
• Measurement of IL-6 mRNA expression, IL-6 protein production, 45Ca release from bone, osteoclast numbers, alkaline phosphatase activity, and collagen synthesis.

Main Results:

• Local bone-resorbing agents (IL-1α, IL-1β, TNF-α, LPS) significantly induced IL-6 mRNA expression in osteoblasts.
• IL-6 production was confirmed in response to IL-1α, TNF-α, and LPS.
• IL-6 dose-dependently stimulated 45Ca release, increased osteoclast numbers, and exhibited synergistic bone resorption with IL-1α.
• IL-6 slightly suppressed alkaline phosphatase activity and collagen synthesis in osteoblasts.

Conclusions:

• Osteoblasts produce IL-6, particularly in response to local inflammatory and bone-resorbing stimuli.
• IL-6 is a potent inducer of bone resorption, acting alone and in concert with other agents.
• IL-6 contributes to bone metabolism by modulating osteoblast activity and promoting osteoclastogenesis.